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Chapter 4
Tau Interaction with Tubulin and Microtubules: 
From Purified Proteins to Cells
Tiphany De Bessa, Gilles Breuzard, Diane Allegro, François Devred, 
Vincent Peyrot, and Pascale Barbier
Abstract
Microtubules (MTs) play an important role in many cellular processes and are dynamic structures regu-
lated by an important network of microtubules-associated proteins, MAPs, such as Tau. Tau has been 
discovered as an essential factor for MTs formation in vitro, and its region implicated in binding to MTs 
has been identified. By contrast, the affinity, the stoichiometry, and the topology of Tau–MTs interaction 
remain controversial. Indeed, depending on the experiment conditions a wide range of values have been 
obtained. In this chapter, we focus on three biophysical methods, turbidimetry, cosedimentation assay, and 
Förster Resonance Energy Transfer to study Tau–tubulin interaction both in vitro and in cell. 
We highlight precautions that must be taken in order to avoid pitfalls and we detail the nature of the con-
clusions that can be drawn from these methods about Tau–tubulin interaction.
Key words Tau protein, Microtubules, Tubulin, Turbidimetry, FRET, Cosedimentation essay, 
Affinity constant
1 Introduction
Microtubules cytoskeleton plays an important role in many cellular 
processes such as mitosis, cellular integrity, cellular shaping, intra-
cellular trafficking, and cell migration. Microtubules (MTs) are 
constantly alternating between polymerization and depolymeriza-
tion phases. This process, called dynamic instability of MT [1], 
is highly regulated by an important network of microtubules- 
associated proteins, MAPs, [2] such as Tau. Since Weingarten’s 
discovery of Tau as an essential factor for microtubule formation 
in vitro [3], the interaction of Tau with tubulin has been inten-
sively studied. However, differential experimental conditions (dif-
ferent buffer, Tau and tubulin peptides, Tau constructs) lead to 
surprising range of Tau–MT affinity values. Studying this interac-
tion is difficult for at least two reasons: the intrinsically disordered 
structure of Tau and the ability of αβ-tubulin dimers to self- assemble 
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into different oligomers depending on the temperature. MTs are 
hollow cylinders formed at 37 °C by a combination of linear pro-
tofilaments, which themselves are formed by αβ-tubulin dimers 
associated heads to tails, forming a pseudohelical lattice [4–6]. 
Tubulin can also self-assemble into other oligomers than MT. For 
example, in solution at 20 °C, addition of magnesium to tubulin 
dimers induces formation of single and doubles rings [7–9]. These 
rings were also described as depolymerization products resulting of 
protofilaments peeling at MTs end [10–12].
Human brain expresses six isoforms of Tau protein produced 
by alternative splicing (exons 2–3 and 10) of a single mRNA [13]. 
The interaction domain of Tau with microtubules, called MT bind-
ing domain (MTBR), is well documented: it is constituted of three 
or four (depending on the isoform) partially repeated sequences 
and a part of N-terminal proline-rich region flanking the MTBR 
[14–17]. By contrast, despite the great number of methods used to 
characterize this interaction, its affinity, the stoichiometry, and the 
topology of binding site on tubulin/MT are still under debate.
In this chapter, we focus on three biophysical methods namely 
turbidimetry, cosedimentation assay, and Förster Resonance 
Energy Transfer (FRET) in living cells used to study Tau–tubulin 
interaction; the use of other useful methods such as analytical 
ultracentrifugation or microcalorimetry has been recently described 
[18–20]. We highlight precautions that must be taken in order to 
avoid  pitfalls and we detail the nature of the conclusions that can 
be drawn from these methods about Tau–tubulin interaction.
2 Materials
Prepare all solutions using ultrapure water and analytical grade 
reagents.
 1. 1 M magnesium chloride (MgCl2) commercial aqueous 
solution.
 2. 1 M ethylene glycol-bis(2-aminoethyl-ether)-N,N,NP,NP- 
tetraacetic acid (EGTA): weigh 7.6 g EGTA in a 20 mL glass 
beaker and add ultrapure water to have just less than 
20 mL. Transfer in a 20 mL graduated flask and adjust volume 
to 20 mL. Put in a plastic tube or glass bottle and store at 
room temperature.
 3. 0.1 M guanosine triphosphate sodium salt hydrate (GTP): 
weigh 0.0567 g GTP in a microtube and add 970 μL of 
 ultrapure water. Check the concentration by measuring the 
absorbance at 256 nm with a molecular extinction coefficient 
ε256 nm = 13,700 M−1 cm−1 and store at −20 °C (see Note 1).
2.1 Tubulin 
Purification
2.1.1 Reagents 
and Solutions
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 4. 400 mM phosphate buffer stock (1 L): mix 27.6 g of NaH2PO4 
H2O with 28.39 g anhydrous Na2HPO4 and add ultrapure 
water to 1 L in graduated flask.
 5. 20 mM phosphate buffer (1 L): put 50 mL of 400 mM phos-
phate buffer in graduated flask and adjust volume to 1 L. pH 
must be at 6.95 at 25 °C.
 6. PM buffer: 20 mM phosphate buffer, 0.5 mM MgCl2. In a 
500 mL glass beaker, add 25 mL 400 mM phosphate buffer 
and 250 μL of 1 M MgCl2 to 450 mL of ultrapure water. 
Adjust pH to 7.0 with 10 M NaOH. Transfer the buffer in a 
500 mL graduated flask and complete volume to 500 mL. Then, 
transfer to a 500 mL cylinder and store at 4 °C.
 7. PMS buffer: 20 mM phosphate buffer, 0.5 mM MgCl2, 0.24 M 
sucrose. In a 4 L glass beaker, add 200 mL 400 mM phosphate 
buffer, 2 mL 1 M MgCl2 and 328.6 g sucrose to 3.5 L of ultra-
pure water. The pH must be at 6.90 without adjustment. 
Transfer in 4 L graduated flask and complete volume to 
4 L. Put in a glass beaker to store at 4 °C.
 8. PMG buffer: 20 mM phosphate buffer, 0.5 mM MgCl2, 
0.1 mM GTP. In a 2 L glass beaker, add 100 mL 400 mM 
phosphate buffer, 1 mL of 1 M MgCl2 to 1850 mL of ultra-
pure water. Adjust pH to 7 with 10 M NaOH. Transfer and fill 
it up to 2 L in a graduated flask and then transfer 250 mL in a 
500 mL glass beaker to be used to prepare PMG 0.4 M KCl 
and keep the 1750 mL left in the 2 L glass beaker and store at 
4 °C. Weigh 0.1056 g of GTP in a microtube and store it at 
-20 °C. GTP will be added to the 1.750 L of PMG Buffer on 
purification day.
 9. PMG 0.8 M KCl: 20 mM phosphate buffer, 0.5 mM MgCl2, 
0.8 M KCl, 0.1 mM GTP. In a 500 mL glass beaker, add 
25 mL of 400 mM phosphate buffer, 250 μL of 1 M MgCl2, 
and 29.84 g KCl to 450 mL of ultrapure water. Adjust pH to 
7.0 with 10 M NaOH and transfer in a 500 mL graduated flask 
to fill it up to 500 mL and transfer 250 mL in another beaker 
to prepare PMG 0.4 M KCl. Keep the 250 mL left in a glass 
beaker to store at 4 °C. Weigh 0.01507 g of GTP in a micro-
tube and store it at −20 °C. GTP will be added in 250 mL 
PMG 0.8 M KCl on purification day.
 10. PMG 0.4 M KCl: 20 mM phosphate buffer, 0.5 mM MgCl2, 
0.4 M KCl, 0.1 mM GTP. In a 500 mL glass beaker, mix 
250 mL PMG buffer and 250 mL of PMG 0.8 M KCl. Verify 
pH and adjust it to 7 with 10 M NaOH if it is necessary and 
store at 4 °C. Weigh 0.03016 g of GTP in a microtube and 
store at −20 °C. GTP will be added in the 250 mL of PMG 
0.4 M KCl on purification day.
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 11. PMG 1 M sucrose: 20 mM phosphate buffer, 0.5 mM MgCl2, 
1 M sucrose, 0.1 mM GTP. In a 500 mL glass beaker, add 
171.2 g sucrose, 25 mL of 400 mM phosphate buffer, 250 μL 
of 1 M MgCl2 and ultrapure water to a volume of 450 mL. Adjust 
pH to 7.0 with 10 M NaOH and transfer in a graduated flask 
to fill it up to 500 mL. Store at 4 °C. Prepare 500 μL of 1 M 
GTP as described in step 3. It will be added in this buffer on 
the purification day.
 12. Microtubule formation buffer: 20 mM phosphate buffer, 
10 mM MgCl2, 3.4 M glycerol, 1 mM EGTA, pH 6.5, 0.1 mM 
GTP. In a 500 mL glass beaker, add 156.4 g glycerol to 
300 mL ultrapure water and mix few minutes to dilute glycerol 
(see Note 2). Then add 25 mL 400 mM phosphate buffer, 
5 mL of 1 M MgCl2, 500 μL of 1 M EGTA and ultrapure 
water to 450 mL. Adjust pH to 6.5 and complete volume to 
500 mL in a graduated flask. Store at 4 °C. 0.1 mM GTP will 
be added freshly.
 13. Sephadex G25 ultra fine: 50 g of Sephadex G25 beads are 
 preincubated overnight in 1 L water ultrapure before use 
(see Note 3).
 14. DEAE A50: weigh 10 g of DEAE A50 in 1 L of 20 mM phos-
phate buffer, pH7.
 15. Guanidine-HCl 6 M: weigh 11.46 g of guanidine-HCl and 
add 20 mL of water (see Note 4).
 1. For slaughterhouse: ice box, plastic bag to put brains, gloves, 
lab coat, and disposable paper.
 2. For purification: big container to boil water, cold room, 
blender, centrifuge and ultracentrifuge and matching tubes 
(18 × 250 mL and 8 × 50 mL), sintered-glass filter and vacuum 
flask, column 3 cm × 50 cm and collector, dialysis tubing : cel-
lulose molecular weight cutoff 3500 Spectra/Por® molecular 
porous n°3 18 mm × 50 ft, nitrogen tank.
 1. Transformed bacteria Escherichia coli BL21DE3 with pET 
containing Tau DNA.
 2. Medium Luria Broth Miller (200 mL) sterilized. Weigh 5 g 
medium in a 200 mL glass beaker and add ultrapure water to 
200 mL. Adjust volume in a graduated flask and transfer in a 
bottle to sterilize and store at 4 °C.
 3. Medium Luria Broth Buffered (1 L) sterilized and supple-
mented with glucose and ampicillin. Weigh 54.8 g medium in 
a 1 L glass beaker and add ultrapure water. Adjust volume in a 
graduated flask and transfer in two bottles to sterilize it. Store 
it at 4 °C.
2.1.2 Special Equipment
2.2 Tau Purification
2.2.1 Reagents 
and Buffers
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 4. Ampicillin 100 mg/mL. Weigh 1 g ampicillin in 15 mL tube 
and add 10 mL ultrapure water. Make 1 mL aliquots and store 
them at −20 °C.
 5. 1 M Isopropyl-beta-D-1-thiogalactopyranoside (IPTG): weigh 
2.4 g in a 15 mL tube and add 10 mL ultrapure water. Make 
1 mL aliquots and store them at −20 °C.
 6. 1 M DL-Dithiothreitol (DTT): weigh 1.54 g in a 15 mL tube 
and add 10 mL ultrapure water. Make 1 mL aliquots and store 
them at −20 °C.
 7. Lysis Buffer (100 mL): 8 mM Triton X100, 45 mM 
2-(N- morpholino) ethanesulfonic acid (MES), 1 mM DTT. 
Weigh 0.5 g Triton and 0.9 g MES. Mix in a 100 mL glass 
beaker with 95 mL of ultrapure water and add 100 μL DTT 
1 M. pH should be around 3.9. Adjust volume with a gradu-
ated flask. Make 10 mL aliquots and store them at −20 °C.
 8. Activation Buffer (500 mL): 45 mM MES, 1 M NaCl. Dissolve 
4.4 g MES and 29 g NaCl in 450 mL ultrapure water in a 
500 mL glass beaker. Increase pH to 6.5 with NaOH and 
complete volume to 500 mL in a graduated flask (see Note 5).
 9. Equilibration Buffer (500 mL): 45 mM MES. Weigh 4.4 g 
MES and dissolve in 450 mL ultrapure water in a 500 mL glass 
beaker. Adjust pH to 6.5 with KOH and complete volume to 
500 mL in a graduated flask (see Note 5).
 10. Elution Buffer (500 mL): 45 mM MES, 0.5 M NaCl. Weigh 
4.4 g MES and 14.5 g NaCl and dissolve them in 450 mL ultra-
pure water in a 500 mL glass beaker. Adjust pH to 6.5 with 
NaOH and complete volume to 500 mL in a graduated flask (see 
Note 5).
Incubator, French press, centrifuge, FPLC apparatus, dialysis 
 tubing: cellulose molecular weight cutoff 3500 Spectra/Por® 
molecular porous n°3 18 mm × 50 ft, freeze-dryer.
 1. 400 mM phosphate buffer, 1 M EGTA, 1 M GTP is prepared 
as described in Subheading 1.
 2. 1 M MgCl2 commercial aqueous solution.
 3. 1 M Tris(2-carboxyethyl)phosphine (TCEP): weigh 1.4 g in a 
5 mL plastic tube, add 4.5 mL ultrapure water. Use a Vortex to 
strongly mix the solution for few minutes (see Note 6). Make 
500 μL aliquots and store them at −20 °C.
 4. Assembly Condition Buffer : 3.4 M glycerol, 20 mM phos-
phate buffer, 1 mM EGTA, 10 mM MgCl2, pH 6.5, 0.1 mM 
GTP, 1 mM TCEP. Microtubule formation buffer is prepared 
as described in Subheading 2.1.1 and 0.1 mM GTP and 1 mM 
TCEP are added freshly before used.
2.2.2 Special Equipment
2.3 Tau–Tubulin 
Interaction 
Experiments 
in Solution
2.3.1 Microtubule 
Formation in Solution
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 5. Non Assembly Condition Buffer: 20 mM phosphate buffer 
pH 6.5, 0.1 mM GTP, 1 mM TCEP. In a 500 mL glass beaker, 
add 25 mL of 400 mM phosphate buffer to 450 mL of ultra-
pure water. Adjust pH to 6.5 with 10 M NaOH. Transfer the 
buffer in a 500 mL graduated flask and complete volume to 
500 mL. Add 0.1 mM GTP and 1 mM TCEP freshly just 
before used.
 6. 10−3 M Paclitaxel: weigh 0.8 mg of paclitaxel in 1 mL in 
dimethyl sulfoxide (DMSO). Its concentration is measured 
spectrometrically with ε273nm = 1,700 M−1 cm-1 in ethanol.
 7. Gravity column (1 cm × 25 cm).
 8. Centrifuge to run at 1,200 × g at 4 °C.
 9. Spectrophotometer and quartz cuvettes.
 1. Glycerol purity superior to 99.5 %.
 2. All buffers and reagents necessary to make SDS-PAGE (poly-
acrylamide gel electrophoresis in denaturing conditions) with 
12 % acrylamide.
 3. SDS PAGE materials.
 4. Ultracentrifuge to run at 88,000 × g at 37 °C.
 1. Uranyl acetate 2 %: weigh 0.2 g uranyl acetate and add 10 mL 
ultrapure water. Mix with vortex and check carefully for the 
dissolution of crystals (see Note 7).
 2. 200 mesh carbon-coated formvar films on copper grids.
 3. Thermostated room at 37 °C.
 4. Transmission electron microscope.
 1. 1.5 × 105 cells (purchased from ATCC, USA).
 2. Growth media: media supplemented with 10 % heat-inactivated 
fetal bovine serum (FBS) (see Note 8).
 3. 8-well Lab-Tek chamber cover glass (Nunc).
 4. Media without FBS (see Note 8).
 5. 10× phosphate buffer saline stock solution.
 6. 10 mM HEPES buffer.
 7. Two plasmid DNA species (1 mg/mL): pEGFP-Tau DNA 
coding for hTau40 protein, the longest human isoform of Tau 
[21], coupled to the fluorescent protein EGFP as an energy 
donor; and pmCherry-α-tubulin DNA coding for α-tubulin 
protein (wild-type α1B isotype) coupled to the fluorescent 
mCherry protein [22] as the energy acceptor.
 8. Commercial transfection reagent such as LipofectAmine 2000 
(Life Technologies, Invitrogen).
2.3.2 Cosedimentation 
Assay
2.3.3 Electronic 
Microscopy
2.4 Tau–Tubulin 
Interactions by FRET 
in Living Cells
2.4.1 Cell Culture, 
Plasmids, and Transfection 
Reagent
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 1. An inverted microscope equipped with a Plan-Apochromat 
63× oil immersion objective (Numerical Aperture = 1.4).
 2. A Confocal Laser Scanning Microscope (CLSM) equipped 
with Argon (488 nm) and Helium–Neon (543 nm) laser lines, 
specific dichroic filter and a spectral mode to select specific 
domains of the emission spectrum (see Note 9).
 3. A photobleaching module coupled to CLSM including 
an observation beam, a photo-destruction beam and a time- 
resolved recording system.
 4. The public-domain ImageJ software [23] and the plug-in 
PixFRET [24] for image analysis.
3 Methods
Tubulin purification necessitates three consecutive days, one 
for materials and buffer preparations and two others for the 
purification.
 1. Equilibrate the ionic exchange resin in 20 mM phosphate buf-
fer. From stock solution 400 mM phosphate buffer, prepare 
1 L of phosphate buffer 20 mM by adding 50 mL of 400 mM 
phosphate buffer in graduated flask and adjust volume to 1 L 
with ultrapure water. Then, weigh 10 g of DEAE-Sephadex 
A50 in a 2 L flask and add 1 L 20 mM phosphate buffer. Put 
this flask in boiling water and let DEAE-Sephadex A50 swell 
for 5 h (see Note 10).
 2. G25 Preparation: pack the Sephadex G25 beads (preincubated 
in ultrapure water overnight) in a column of 50 cm high and 
3 cm diameter (3 cm × 50 cm). Leave 2 cm at the top of the 
column to add the sample. Equilibrate it with 400 mL PM 
buffer at a 1 mL/min flow rate (see Note 11).
 3. Chemical preparation: crush ammonium sulfate crystals in 
powder to dissolve it easier.
 4. Weigh GTP samples as described in Subheading 2.1.1 and 
store it at −20 °C.
 5. Material and room preparation: clean and organize the cold 
storage room. Dispose of materials.
The brains (fifteen lamb or pig brains) should be collected just 
after the animal death in the slaughterhouse and put them in  plastic 
bag and rapidly in ice box for the transport. From there, conduct 
all the experiments in a cold room to prevent tubulin denaturation. 
Nitrile gloves are used for all purification steps and workers must 
wear mask during brain homogenization.
2.4.2 Confocal Laser 
Scanning Microscopy
3.1 Tubulin 
Purification
3.1.1 Tubulin Purification 
(Day 1)
3.1.2 Tubulin Purification 
(Day 2)
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 1. Brain homogenization: remove superficial blood vessels and 
meninges from brains with dissection pliers. Cut and rinse 
them with an equal volume of PMS (do not exceed 2.5 L) that 
will be eliminated through gauze. Repeat this step three times. 
Add PMS (total volume must not exceed 3 L to limit centri-
fuge run numbers) to brains and homogenize them in a blender 
for 30 s.
 2. To eliminate membranes and cellular fragments, homogenate 
is centrifuged in 12 tubes (250 mL) at 13,000 × g for 30 min at 
4 °C (see Note 12). During this centrifugation, add GTP to 
PMG buffer, PMG 0.4 M KCl and PMG 0.8 M KCl. Equilibrate 
G25 with 400 mL PMG at a flow rate of 1 mL/min. Begin 
DEAE-Sephadex A50 equilibration: get rid of the buffer 
by filtration with sintered-glass filter and vacuum flask. Add 
250 mL PMG buffer to Sephadex beads and increase pH to 
6.7 with few drops of 10 M NaOH. Get rid of the buffer as 
described above and add 250 mL PMG buffer.
 3. Ammonium sulfate fractionation 32 %: discard pellets (see Note 
13) and measure supernatant volume with cylinder. Put it in a 
2 L glass beaker and add slowly 177 g of ammonium sulfate 
per liter of supernatant. When ammonium sulfate is completely 
dissolved, wait for 10 min.
 4. Centrifuge the precipitate at 13,000 × g for 30 min at 4 °C in 
six tubes of 250 mL (see Note 12). During this second cen-
trifugation, continue to equilibrate DEAE-Sephadex A50: 
increase pH to 6.8 with 10 M NaOH, throw out buffer and 
add 250 mL PMG buffer. Increase pH to 6.9 and throw out 
buffer. Add 250 mL PMG buffer. DEAE-Sephadex A50 is 
ready to use.
 5. Ammonium sulfate fractionation 43 %: discard pellets (see Note 
13) and measure the supernatant volume with cylinder. Put it 
in a 2 L glass beaker and add slowly 71 g of ammonium sulfate 
per liter of supernatant. When ammonium sulfate is completely 
dissolved, wait for 10 min.
 6. Centrifuge the precipitate at 13,000 × g for 30 min at 4 °C 
(see Note 12). Discard the supernatant. Collect pellets with 
spatula and suspend them by gentle mixing in a 100 mL glass 
beaker. Wash thoroughly centrifugation tubes with PMG buf-
fer. Do it three times but do not exceed a final volume of 
40 mL PMG buffer (see Note 14).
 7. DEAE A50: the protein solution is then mixed with 250 mL of 
the DEAE-Sephadex A50 which has been previously equili-
brated in PMG buffer. Incubate for 10 min with gentle agita-
tion. Get rid of buffer by filtration on sintered-glass filter and 
vacuum flask. Eliminate filtrate and add 200 mL of PMG 
0.4 M KCl on DEAE-Sephadex A50 containing sample. 
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Incubate with gentle agitation for 5 min. Get rid of buffer by 
filtration as described above twice. Change vacuum flask to 
keep filtrate. Add 125 mL PMG 0.8 M KCl, wait 5 min and 
eluate tubulin by filtration. This step has to be repeated twice.
 8. Add slowly 62 g ammonium sulfate to the 250 mL of filtrate in 
a 500 mL glass beaker and wait for 5 min with gentle agitation 
after total ammonium sulfate dissolution.
 9. Centrifuge at 66,000 × g for 25 min at 4 °C (see Note 12). 
Discard the supernatant and collect pellets with spatula and 
suspend them by gentle mixing in a 100 mL glass beaker. Wash 
thoroughly centrifugation tubes with PMG buffer. Do it three 
times but do not exceed a final volume of 20 mL PMG buffer 
(see Note 14). The totally dissolved pellets will be passed 
through Sephadex G25 chromatography.
 10. Sephadex G25 chromatography: when the PMG buffer com-
pletely entered in the resin, load carefully the protein solution. 
When half of the mix is in the column add buffer on the top 
without mixing solutions (see Note 15). Eluate with a 1 mL/
min flow rate and collect fractions of 3–3.5 mL. In tubes con-
taining protein where a meniscus is observed (use plastic 
tubes), add 1 M MgCl2 to have a final concentration of 30 mM 
(110 μL for 3.5 mL). Mix by inverting and collect all samples 
in which white precipitate is instantaneously observed. Gather 
them in centrifugation tubes.
 11. Centrifuge at 9,000 × g for 10 min at 4 °C (see Note 12). 
During this centrifugation, add 500 μL 0.1 M GTP to the 
500 mL of PMG sucrose buffer.
 12. Collect pellets and dissolve them in a minimum volume of 
PMG sucrose buffer (do not exceed 5 mL) with gentle agita-
tion (see Note 14).
 13. The solution is placed in a dialysis tubing (cellulose molecular 
weight cutoff 3500, Spectra/Por® molecular porous n°3 
18 mm × 50 ft) and dialyzed for 16 h against PMG sucrose buf-
fer supplemented with 0.1 mM GTP.
 1. Collect tubulin from the dialysis tubing and centrifuge it at 
12,000 × g for 30 min at 4 °C (see Note 12). Discard pellets 
and keep the supernatant. Make 300 μL aliquot in cryotubes 
and stock them in liquid nitrogen. Store 2 mL of dialysis 
buffer.
 2. Tubulin concentration is determined by spectrophotometry. 
Put 5 μL of dialysis buffer in 500 μL of 6 M Guanidine-HCl 
and make the blank. Put in triplicate 5 μL of tubulin sample in 
500 μL and measure the absorbance at 275 nm. Determine the 
concentration using the Lambert–Beer law with a molecular 
extinction coefficient of ε275 nm = 1.09 mL mg−1 cm−1 taking into 
account the dilution factor (here 101).
3.1.3 Tubulin Purification 
and Storage (Day 3)
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 3. Test the tubulin capacity to form microtubules using a 
 turbidimetry assay (see Subheading 3.3.2).
At the end of the purification, you should have 200–300 mg 
of pure tubulin at 40–80 mg/mL and an absorbance variation of 
about 0.5 for 30 μM (3.0 mg/mL) of tubulin corresponding to 
microtubule formation (Fig. 1).
 1. Switch on the “Hoffman heater” 30 min before the beginning 
of the bacterial growth (see Note 16).
 2. Near the “Hoffman heater” in a 500 mL Erlenmeyer flask, mix 
100 mL sterilized medium Luria Broth Miller with 100 μL 
Ampicillin and 100 μL stock bacteria. Place it in an incubator 
at 37 °C overnight with agitation.
 1. Switch on the “Hoffman heater” 30 min before the beginning 
of bacterial growth (see Note 16).
 2. Near the “Hoffman heater” first, remove 5 mL medium with-
out bacteria to make blank to read absorbance and second, in 
each two 2 L Erlenmeyer flask, 500 mL sterilized medium Luria 
Broth Buffered are mixed with 1.85 g glucose, 100 μL ampicil-
lin, and 10 mL pregrowth bacteria. Place them in an incubator 
at 37 °C with agitation for few hours. Read absorbance at 
3.2 Tau Purification
3.2.1 Bacterial 
Pregrowth
3.2.2 Bacterial Culture
Fig. 1 Tubulin purification: (A) MT formation time course at 350 nm of 30 μM of purified tubulin in assembly 
conditions at 37 °C. At time indicated by arrow, the temperature is decreased to 10 °C. (B) 12 % SDS-PAGE of 
Tubulin that migrates in one band at 50 kDa. (C) Electronic microscopy of the MTs sample. The white scale bar 
represents 1 μm
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600 nm every hour until it reaches a value between 0.6 and 1. 
At this moment add 750 μL of 1 M IPTG to induce protein 
expression and incubate for 2 h 30 min.
 3. Centrifuge at 5,000 × g for 10 min at 4 °C and remove super-
natant. Pellets are recovered and dissolved in lysis buffer 
(see Note 17).
 1. Apply twice on the dissolved pellet a 4 t pressure in French 
press.
 2. Boil the bacterial lysate at 90 °C for 10–15 min, to select 
thermal- resistant proteins like Tau.
 3. Centrifuge for 30 min at 30,000 × g at 4 °C (see Note 12). 
Keep the supernatant (see Note 17).
 1. Chromatography preparation (see Note 18): A SP Sephadex® 
High Performance 5 mL column is activated by passing 5 mL 
(one column volume) of activation buffer (45 mM MES, 1 M 
NaCl) with a NaCl gradient of 0–100 % (mix with equilibra-
tion buffer constituted of 45 mM MES) at a flow rate of 1 mL/
min. Beads are rinsed with 3 column volumes (15 mL) of acti-
vation buffer. Reverse the NaCl gradient from 100 to 0 % in 
5 mL. Before sample injection, column is washed with 15 mL 
of equilibration buffer.
 2. Start to collect 5 mL fractions and inject sample with equilibra-
tion buffer at a flow rate of 0.5 mL/min. Absorbance increases 
during sample deposit (resin–protein interaction). Rinse col-
umn with equilibration buffer as far as absorbance comes back 
to baseline level and then begin elution.
 3. Apply a 30 % NaCl gradient: increase the salt concentration to 
30 % in two column volumes (10 mL) with a flow rate of 
1 mL/min. Apply it as long as absorbance is constant.
 4. Increase the salt gradient to 70 % in one column volume (5 mL) 
with a flow rate of 1 mL/min. Tau is released at this step. 
When Tau protein has been released from the column, a 100 % 
 gradient is applied to wash column for few minutes at a flow 
rate of 1 mL/min.
 5. To verify that Tau is present in fractions or to know if there is 
no Tau in flow through, you may take 20 μL of each fraction, 
add 5 μL of loading buffer 5× and depose them on SDS PAGE 
12 % acrylamide (see Note 17).
 6. Fractions containing Tau are pooled in a dialysis tubing (cel-
lulose molecular weight cutoff 3500, Spectra/Por® molecular 
porous n°3 18 mm × 50 ft) and dialyzed for 2 h, three times 
against ultrapure water. Then, Tau is collected and frozen at 
−80 °C to be lyophilized. Once lyophilized, Tau can be stored 
at −20 °C for several months.
3.2.3 Proteins Extraction
3.2.4 Tau Purification
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 7. Before use, Tau is dissolved in the desired buffer, centrifuged 
at 3,000 × g for 10 min and its concentration is determined 
by spectrophotometry using the extinction coefficient ε280nm = 
7,700 M−1 cm−1 after light scattering correction (Fig. 2).
Microtubule formation is a cooperative system that needs in vitro 
a tubulin minimum concentration called “tubulin critical con-
centration” (Cr). Cr is defined as the inverse of the apparent 
MT-elongation constant Kapp [25]. To determine Cr, we measured 
microtubule amount by turbidimetry or sedimentation assay 
(tubulin concentration in the pellet) as a function of total tubulin 
concentration and fit the results to a linear regression. The Cr 
 corresponds in this case to the value of x (tubulin concentration) 
found for y = 0 (no microtubule formation). More accurately, mea-
suring the concentration found in the supernatant of sedimenta-
tion assay of microtubule solution leads directly the Cr value. This 
value is dependent of the experimental conditions. It is well known 
that magnesium ions, glycerol, dimethyl sulfoxide, sucrose are pos-
itive factors that reduce the Cr. For example, Cr of tubulin is 7 μM 
3.3 Tau–Tubulin/
Microtubule 
Interaction in Solution
Fig. 2 Tau purification: (A) 12 % SDS-page of purified Tau protein. As largely described in literature, the largest 
441 amino acid long isoform migrate at an apparent molecular mass of approximately 65 kDa. (B) Concentration 
determination by UV–visible wavelength scan of Tau protein. The line A corresponds to the light diffusion that 
should be subtracted to the scan to not sur-estimate the concentration. The corrected absorbance at 280 nm 
(line B) is then used to determine the Tau concentration. (C) Typical time course of MTs formation at 37 °C 
induced by Tau. Tubulin concentration is 5 μM is mixed with no (dark line) or 3.5 (dash-dot line), 4.2 (dot line) 
and 5 μM of Tau (dash line). The arrow indicates the Tau addition
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in 20 mM phosphate buffer, 3.4 M glycerol, 1 mM EGTA, 10 mM 
MgCl2, 0.1 mM GTP, pH 6.5 [26] and 20 μM in 80 mM K-Pipes, 
1 mM MgCl2, 1 mM EGTA, GTP 1 mM pH 6.8 [27]. In these 
conditions, called in this chapter as “assembly conditions buffer,” 
presence of Tau leads to a microtubule formation facilitated by 
ligand binding. In 2004, we found experimental conditions in 
which the presence of Tau induces the microtubule formation in 
the absence of any other known polymerization factors (20 mM 
phosphate buffer pH 6.5, 0.1 mM GTP, 1 mM TCEP) (see Note 6). 
In this condition, called in this chapter “non-assembly condition,” 
presence of Tau leads to a microtubule formation induced by ligand 
binding [28].
Before using tubulin it is necessary to eliminate sucrose. Tubulin is 
equilibrated (see Note 19) in the appropriate buffer (assembly or 
non-assembly condition) on gel filtration Sephadex G25 resin on a 
gravity column (1 cm*25 cm).
 1. Equilibrate the column with cold 40 mL of appropriate buffer 
at a flow rate of 1 mL/min and defreeze rapidly tubulin 
sample.
 2. When the buffer is removed (without completely drying the 
resin), put tubulin solution (see Note 20) on the top. When all 
the protein entered in the resin, put the buffer and start elu-
tion at a flow rate of 1 mL/min. Collect 500 μL fractions and 
put them on ice. The tubulin concentrations into the tubes 
with meniscus (see step 10 in Subheading 3.1.2) are deter-
mined by spectrophotometry as described in Subheading 3.1.3 
with elution as control instead of dialysis buffer.
Tubulin prepared as described above is diluted to 7.5 μM in the 
appropriate buffer to be at a tubulin final concentration of 5 μM 
(this concentration is under the 7 μM Cr for the assembly 
 condition). Sample volume and number of samples depend on the 
spectrophotometer (for us, it is 300 μL and six samples).
 1. Before starting the time-driven microtubule formation, make 
blank on the spectrophotometer with buffer alone.
 2. Put 200 μL of tubulin at 7.5 μM in the six different cuvettes 
and put them on ice.
 3. Put rapidly the cuvettes in the spectrophotometer thermo-
stated at 37 °C and measure the absorbance time course at 
350 nm for 5 min. You may have to wipe condensation off.
 4. Add rapidly in each cuvettes 100 μL of buffer for control or 
different Tau concentrations (from 0.5 to 5 μM). Do not use 
Tau concentration above the tubulin concentration because it 
induces microtubule bundling [28]. The signal should increase 
rapidly indicating microtubule formation. The turbidity is 
3.3.1 Tubulin Preparation
3.3.2 Turbidimetry Assay
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observed for 30 min (Fig. 2). The samples then can be used for 
cosedimentation assay and/or electron microscopy.
 5. Mix 15 μM of tubulin prepared as described in Subheading 3.3.1 
in 20 mM phosphate buffer, 8 mM MgCl2, pH 6.5, 1 mM 
TCEP with 15 μM of paclitaxel, a microtubule inducer and 
stabilizing agent.
 6. Incubate for 25 min at 37 °C. At this stage the solution is 
opaque due to the microtubule formation.
 7. Dilute the paclitaxel-stabilized microtubules (200 μL) to 
7.5 μM.
 8. Mix 200 μL of paclitaxel-stabilized MT with 100 μL of buffer 
or different concentrations of Tau from 0.5 to 20 μM. After 
5 min, take 10 μL for transmission electron microscopy and 
200 μL for cosedimentation assays.
Microtubule and Tau bound to microtubule are separated from 
free Tau and tubulin by centrifugation. To prevent nonspecific 
association, centrifugation is conducted on 60 % glycerol cushion.
 1. Prepare the glycerol cushion by adding 60 mL of glycerol to 
40 mL of appropriate buffer and form microtubules as 
described in the Subheading 3.3.2.
 2. Place 200 μL samples on 200 μL glycerol 60 % in ultracentri-
fuge tubes pre-warmed at 37 °C and centrifuge at 88,000 × g 
for 20 min at 37 °C in a pre-warmed rotor.
 3. Collect supernatant (200 μL) containing free Tau and tubulin 
and mix it with 40 μL of 5× SDS-PAGE loading buffer. Turn 
upside down the tubes containing the pellets to remove the 
rest of supernatant.
 4. Wash the pellets containing MT and bound Tau tactfully with 
200 μL of warm (37 °C) buffer to eliminate free Tau and free 
tubulin. Repeat this step three times.
 5. Dissolve the pellet in 200 μL cold buffer to depolymerize 
microtubules. A manual action may be necessary to suspend 
correctly pellets. Add 40 μL of 5× SDS-PAGE loading buffer 
to the 200 μL dissolved pellets.
 6. Heat samples at 95 °C before loading it in a 12 % SDS-PAGE.
 7. 10 μL of pellets and supernatants are loaded on a same 12 % 
SDS-PAGE to eliminate error due to coloration variation. 
Protein content is revealed by Coomassie Brilliant Blue stain-
ing. To quantify free and bound tubulin and free and bound 
Tau, loading of each sample must be readjusted to obtain 
 comparable and non-saturated spots. Protein quantification  
is determined with band intensity quantification by ImageJ. 
3.3.3 Cosedimentation 
Assays: Microtubules 
Bound Tau, Free Tau, 
and Free Tubulin 
Separation
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The experiments must be done three times to have a representative 
average. Because Tau concentration in the pellet represents 
MT-bound Tau concentration and that in the supernatant the 
free one, Scatchard plot can be used to determine affinity con-
stant and the stoichiometry of the reaction. For analysis used 
the following equation:
 
B
Tau
nK BK
[ ]
= -
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a a
 
where B is the ratio of the concentration of bound ligand (here 
Tau in the pellet) to total available binding sites (total tubulin 
concentration), [Tau]free is the concentration of free Tau, n is 
the number of binding sites, and Ka the affinity constant of Tau 
for the microtubule. Plotting this data, B/[Tau]free versus B, 
yields the Scatchard plot with a slope −Ka and an x-intercept 
leads to n. This approach can be used only in the case of study-
ing Tau interaction with paclitaxel-stabilized MT. For the two 
other conditions, Scatchard plots are curved downward reflect-
ing the fact that ligand-induced tubulin assembly may proceed 
by a ligand facilitated elongation (in assembly conditions) in 
which the elongation precedes the binding of Tau (Eq. 1) or a 
ligand-mediated elongation pathway (in non- assembly condi-
tions), in which the binding of Tau, to either tubulin or micro-
tubule, precedes the elongation pathways (Eq. 2) [28].
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Equation 1 is characterized by an apparent elongation constant 
Kapp = K2(1 + K1[Tau]free) (for more details, see the appendix of 
ref. [29]) and Eq. 2 is characterized by an apparent elongation 
constant Kapp = K1K2[Tau]free/(1 + K1[Tau]free). As already men-
tioned in Subheading 3.3, the Kapp is related to 1/Cr and the 
Cr corresponds to the free tubulin concentration in the super-
natant of the cosedimentation assay. So plot Kapp in function of 
free Tau concentration and fit the data with the equation of 
Kapp described above. Use Eq. 1 in assembly condition and 
Eq. 2 in non-assembly condition.
 1. Removed 10 μL at the end of microtubule formation reaction 
(see Note 21).
 2. Put down on a Parafilm sheet a 200 mesh carbon-coated form-
var films on copper grids
 3. Put a little drop of samples (3 μL) on grids and incubate 
for 15 s.
3.3.4 Transmission 
Electronic Microscopy
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 4. Eliminate the excess of sample by taking the grid with tweezer 
and absorb sample with filter paper (apply the grid 
per pen dicularly).
 5. Add 3 μL uranyl acetate on the grid for 30 s for staining.
 6. Eliminate uranyl acetate exceed as describe in step 4.
 7. Dry grids overnight at 37 °C and observe it using a transmis-
sion electron microscope.
The transfection protocol is performed as recommended by the 
supplier (LipofectAmine 2000, Life technology, U.S.). For cell 
transfection, 0.4 μg of DNA (0.4 μg of pEGFP-Tau DNA in well 
1, 0.4 μg of pmCherry-α-tubulin DNA in well 2, 0.2 μg of pEGFP- 
Tau DNA and 0.2 μg of pmCherry-α-tubulin DNA in well 3) are 
applied on cells. After transfection, the well 1 contains cells express-
ing EGFP-tau proteins (corresponding to the condition “donor 
alone”), the well 2 contains cells expressing mCherry-α-tubulin 
proteins (corresponding to the condition “acceptor alone”), and 
the well 3 contains cells expressing both EGFP-tau and mCherry- 
α- tubulin proteins (corresponding to the condition “uFRET”). 
Cells are observed after 24–48 h post-transfection.
 1. Place cells in medium supplemented with 1 % FBS and 10 mM 
HEPES to reduce pH variations (see Note 22), and maintain 
cells at 37 °C.
 2. Configure the CLSM’s settings such as imaging conditions are 
optimized before data collection (see Note 23). The donor 
EGFP-tau is excited sequentially at 488 and 543 nm and the 
fluorescence emission is collected using the CLSM’s spectral 
mode simultaneously between 496 and 535 nm (channel 1, 
corresponding to the donor settings: excitation of the donor, 
detection of the donor) and between 580 nm and 650 nm 
(channel 2 corresponding to the uncorrected FRET (uFRET) 
settings: excitation of the donor, detection of the acceptor) 
(see Note 23). The acceptor mCherry-α-tubulin is then excited 
at 543 nm and the fluorescence emissions are collected between 
580 and 650 nm (channel 3 corresponding to the acceptor set-
ting: excitation of the acceptor, detection of the acceptor).
 3. Adjust gain and offset of the donor and uFRET channels with 
cells expressing EGFP-tau alone. The pixel intensities must be 
linear with the total dynamic scale of fluorescence intensities 
(for example 256-grey scale for an 8-bit image depth) 
(see Notes 24 and 25). Collect three images of cells on the 
field.
 4. Adjust gain and offset of the acceptor channel exclusively 
with cells expressing mCherry-α-tubulin alone (see Note 26). 
Collect three images of cells on the field.
3.4 Tau–Tubulin 
Interactions by FRET 
in Living Cells
3.4.1 Transfection 
Protocol with Plasmids 
DNA
3.4.2 Confocal Imaging: 
FRET Measurement 
by Sensitized Emission
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 5. Image cells expressing the donor and acceptor pairs through 
the donor, the uFRET and the acceptor settings previously 
adjusted in steps 3 and 4.
An alternative method to quantify the absolute efficiency of FRET 
between the donor EGFP-tau and the acceptor mCherry-α- tubulin 
is to measure the EGFP emission before and after selective photo-
bleaching of the mCherry [30].
 1. Place cells expressing both the donor and the acceptor in 
medium supplemented with 1 % FBS and 10 mM HEPES 
to reduce pH variations (see Note 22), and maintain cells at 
37 °C.
 2. Configure the CLSM settings such as: EGFP-tau is excited at 
488 nm and the fluorescence emission is collected using the 
CLSM’s spectral mode between 496 and 535 nm; and 
mCherry- α- tubulin is excited at 543 nm and the fluorescence 
emission is collected between 580 and 650 nm. The donor and 
acceptor fluorophores are sequentially excited.
 3. Adjust gain and offset of the donor channel with cells express-
ing EGFP-tau alone so that as the fluorescence intensity of 
EGFP-tau does not saturated PMT (see Note 27).
 4. Adjust gain and offset of mCherry-α-tubulin channel with 
cells expressing mCherry-α-tubulin alone. The pixel intensities 
must be linear with the total dynamic scale of fluorescence 
intensities (for example 256-grey scale for an 8-bit image 
depth).
 5. Collect two images of cells with the 488 and 543 nm excita-
tion lines with donor and acceptor settings as previously 
described in steps 3 and 4 (see Note 28).
 6. Irradiate the acceptor on a region of interest (ROI) in the cell 
using 100 % laser power with a 543 nm exciting beam. As 
reported in ref. [30], mCherry-α-tubulin was photobleached 
for 31.56 s (25 frames) on a 6 × 6 μm2 ROI (see Note 29).
 7. Recollect two images of cells with the 488 and 543 nm excita-
tion lines after the mCherry-α-tubulin photobleaching in the 
ROI.
The ImageJ plug-in PixFRET (Center for Integrative Genomics, 
Faculty of biology and medicine, University of Lausanne, 
Switzerland) [24] can generate images of sensitized-emission 
FRET, and hence show where FRET occurs within a cell or a group 
of cells, by computing pixel by pixel the images of a sample acquired 
in a three channel setting.
 1. For donor Spectral Bleed-Through (SBT) determination, cre-
ate a stack of donor and uFRET images of cells expressing 
EGFP-tau alone.
3.4.3 Confocal Imaging: 
FRET Measurement 
by the Acceptor 
Photobleaching
3.4.4 FRET Calculation 
for Sensitized- Emission 
FRET
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 2. Select a ROI manually by outlining cells on the donor image 
and determine the mean fluorescence intensity of the ROI in 
the Analyze menu of ImageJ software; do the same measure 
of the mean fluorescence intensity on the uFRET image 
(see Note 30).
 3. Calculate the intensity ratio of the uFRET on donor images; 
the mean value of all intensity ratios corresponds to the donor 
SBT parameter A (see Note 31).
 4. Repeat steps 1–3 to calculate the acceptor SBT parameter B 
with images of cells expressing mCherry-α-tubulin alone.
 5. Before starting the PixFRET plug-in, create a stack of three 
images of the cell or the group of cells expressing both the 
donor EGFP-tau and the acceptor mCherry-α-tubulin: 
the first one in the uFRET setting, the second one in the donor 
setting and the third one in the acceptor setting.
 6. Launch PixFRET from the plug-ins menu in ImageJ.
 7. Enter the value for the donor and acceptor SBTs in the Donor 
and Acceptor Models bookmarks, respectively (see Note 32), 
and click on the FRET bookmark to select a ROI on the stack 
in order to determine the background outside cells; press Get 
button.
 8. In the parameter box below, select “no Gaussian Blur” and a 
value of 1.0 for threshold correction factor (see Note 33), as 
well as the type of normalization of the FRET values among 4 
possibilities: by dividing by the donor or the acceptor intensity 
[31], by the product of donor and acceptor intensities [32] or 
by the square root of the product of donor and acceptor inten-
sities [33]; users can also generate an image displaying the 
FRET efficiencies in the sample. For example, the methodol-
ogy reported in ref. [30] was to normalize corrected FRET 
(Fc) to the donor intensity.
 9. Click on “Compute FRET” button to generate the normal-
ized FRET image, in addition to the Fc image calculated from 
the formula described by ref. [34]:
 
Fc FRET donor acceptor= - ´ - ´I A I B I  
Where IFRET, Idonor, and Iacceptor are pixel intensities (subtracted 
from their background intensity) in cells under the distinct 
uFRET, donor, and acceptor settings, respectively. The param-
eters A and B were calculated in steps 3 and 4.
 10. To reduce background noise, prefer to use a nonlinear filtering 
of the computed FRET image with for example a 1-pixel- range 
median filter than a Gaussian filter [35, 36].
Tiphany De Bessa et al.
79
 11. In the Image menu of ImageJ, select an adequate LookUp 
Table (LUT) and adjust brightness and contrast to take over all 
the dynamic scale of fluorescence intensities (see Note 34).
 12. Save the computed FRET images as a TIFF file.
 1. With ImageJ software [23], create a stack of four images of 
cells expressing EGFP-tau and mCherry-α-tubulin before and 
after the acceptor photobleaching.
 2. On the post-bleaching image of mCherry-α-tubulin, select 
manually a ROI overlaying the bleached zone.
 3. Place on the pre-bleaching image of the donor with the 
horizontal scrollbar in the stack and determine the mean 
fluorescence intensity of the ROI using the Measure function 
of the Analyze menu in ImageJ.
 4. Do the same measure of the fluorescence intensity on the post- 
bleaching image of the donor.
 5. Calculate the FRET efficiency (%E) from fluorescence recovery 
after the photobleaching kinetic of the donor emission in the 
presence of the acceptor in ROIs [37]:
 6. Return to step 2 and select manually a ROI in another zone of 
the cell; determine the mean fluorescence intensity of the ROI 
on pre- and post-bleaching images of the donor and calculate 
%E which must be significantly lower than for the bleached 
zone (see Note 35). For example, we obtained %E of 8.7 ± 0.2 
for EGFP-tau in the mCherry-α-tubulin bleached zone vs. %E 
of 1.1 ± 0.1 in a control zone (unpublished data) (see Note 36).
 
% /E I I= ( ) ( )-1 donor pre-bleaching donor post-bleaching  
where (Idonor)pre-bleaching and (Idonor)post-bleaching are the donor emis-
sion before and after selective photobleaching of the acceptor, 
respectively.
 7. We recommend completing data with figure showing location 
of the fluorescence variation of EGFP-tau and mCherry-α- 
tubulin before and after the acceptor photobleaching, as the 
example reported in Fig. 3.
4 Notes
 1. GTP is dissolved in water. Make Aliquots of 100 μL and store 
them at –20 °C. GTP should be added freshly to buffer to 
avoid hydrolysis of GTP into GDP which is inactive for MTs 
formation.
 2. Glycerol is viscous. Precautions should be taking to be sure 
that it was accurately mixed with buffer or water.
3.4.5 FRET Calculation 
for FRET by the Acceptor 
Photobleaching
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 3. Add a pinch of azide to prevent bacteria or fungus growth. 
After use, unpacked resin, wash ten times with ultrapure water. 
It can be used ten times.
 4. In the case of guanidine-HCl, the volume increases when it is 
dissolved and the reaction is endothermic. Do not put a vol-
ume of water larger than the half of the total volume.
Fig. 3 Energy transfer between EGFP-tau and mCherry-a-tubulin revealed by the acceptor photobleaching in 
living cells. The quenched and unquenched EGFP-tau emission is compared after specific photobleaching of 
the mCherry-α-tubulin fluorophore (respectively, upper and lower panels in false colors under Pre- and Post- 
bleaching titles). Prior to the acceptor photobleaching, microtubules and uniformly labeled with EGFP-tau; after 
photobleaching, the fluorescence emission of EGFP-tau increased in spots along microtubules (black arrows 
in upper panel) confirming FRET in the initial state; no significant fluorescence intensity fluctuation is observed 
inside the control region. Scale bar: 10 mm; side bars: color pixel scoring for fluorescence intensities from 0 
(dark purple) to 255 (red); EGFP-tau and mCherry-α-tubulin are excited at 488 and 543 nm respectively, using 
the multi-tracking mode of CLSM system
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 5. All FPLC buffers can be stored at room temperature for few 
months.
 6. TCEP powder is very difficult to dissolve at concentration of 
1 M. TCEP is preferred to DTT to reduce disulfide bonds 
because it is more stable. It is used to maintain Tau monomeric 
and have no effect on MTs formation.
 7. This solution must be filtered just before use to remove crys-
tals or possible pollutants which perturb coloration. To use 
uranyl acetate use gloves.
 8. Add 2 mM L-glutamine and nonessential amino acids if absent 
in media both to stimulate growth and to prolong the viability 
of cells in culture.
 9. We use a Leica DMI6000CS inverted microscope coupled to a 
CLSM Leica TCS SP5, with the TD488/543/633 dichroic 
filter equipping the system.
 10. During DEAE swelling, you must check there is always enough 
water and that it is boiling.
 11. The resin must not be dried. Keep an eye on column when 
already 500 mL went through.
 12. Think to thermostat centrifuge and rotor and tubes at the 
good temperature before run.
 13. Collect all wastes in a special bag to eliminate them in rules 
respect.
 14. Wash all tubes meticulously with spatula and collect all vol-
umes, as little as they are, to optimize the output. Start using 
spatula to crash pellet and then use a magnetic stirring bar 
which has almost the same length as glass beaker diameter and 
finish by gently by gently pipetting in and out the sample with 
a 1 mL pipetman without making bubbles. It is very important 
to suspend every tiny particle.
 15. When you add buffer on the top of mixing solution a biphasic 
layer formed. It is the sign that tubulin is here and concentrated.
 16. Do not wear gloves when you work near a heat source but 
handle carefully bacteria samples and wash hands after 
experiments.
 17. Pellets can be kept in lysis buffer at −20 °C for few weeks or 
experiment can continue. If sample is frozen, defreeze and 
homogenize it before use.
 18. Make sure that the instrument is ready to start (flow rate, good 
pressure, no leakages, no blocks).
 19. Tubulin is sensitive to temperature. So all steps to prepare it 
must be made at 4 °C in a cold room or ice box with cold 
buffer.
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 20. If you put 150 μL of tubulin solution at 670 μM, that 
 corresponds to 10 mg of protein and you recuperate 6–7 mg 
into four tubes at an average of approximately 35 μM corre-
sponding to the 2/3 of the amount of protein put initially 
onto the column.
 21. To maintain MT, grids preparation is made in a thermostated 
room at 37 °C at room temperature, because rings of tubulin 
might form.
 22. Do not add 10 mM Hepes to the medium if the CLSM is 
equipped with a heat- and CO2-regulated chamber.
 23. Use samples expressing the donor or the acceptor fluorophores 
alone to maximize uFRET signals, to minimize SBT, to avoid 
widespread saturation, to avoid unintended photobleaching, 
and to minimize background noise [34].
 24. Avoid images showing pixels with saturated intensity indicat-
ing an excessive excitation laser power.
 25. The same PMT settings in donor and acceptor channels and 
low laser power are recommended, in order to generate a 
robust uFRET signal at donor excitation in the acceptor chan-
nel, without at the same time saturating the donor emission 
signal in the donor channel.
 26. Do not modify gain and offset of the uFRET channel, other-
wise to calculate wrong donor and acceptor SBT (parameters 
A and B in the FRET calculation in the Subheading 3.4.4).
 27. We recommend adjusting gain and offset of the donor channel 
in order to spread fluorescence intensities on two-thirds of the 
dynamic intensity scale.
 28. Users can focus on two cells in the same image, a first cell on 
which users irradiate a ROI to photobleach the acceptor and 
another cell as control.
 29. On our CLSM with a 63 × 1.4 NA objective, these conditions 
destroy mCherry with very little or no direct bleaching of the 
EGFP donor. The optimal exposure conditions that bleach accep-
tor maximally with minimal direct effect on donor should be 
determined for each microscope system and filter set, using for 
example droplets of donor and acceptor under oil, cells transfected 
with donor and acceptor fusion proteins alone, or cells co-trans-
fected with non-interacting donor and acceptor fusion proteins.
 30. Keep the same selected ROI in the donor image while switch-
ing on the uFRET image.
 31. The main causes of bleed-through are the emission of the 
donor in the acceptor channel and the excitation of the  acceptor 
when exciting the donor. To calculate donor (and acceptor) 
SBTs, average fluorescence intensities in cells expressing only 
the donor (or the acceptor) should be quantified, both in the 
uFRET and in donor (or acceptor) channels. The SBT ratios 
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are the ratios between the fluorescence intensities in each 
channel after background subtraction, such as:
 – For the parameter A: A = (IFRET/IDonor)Exc 488nm
When the donor alone is expressed and excited at 488 nm;
 – For the parameter B: B = (IFRET)Exc 488nm/(IAcceptor)Exc 543nm
 When the acceptor alone is expressed and excited at both 
488 and 543 nm.
 32. Keep the value 0 for FRET and Donor/Acceptor boxes in the 
Background sections; press Accept button; in the Model 
Donor/Acceptor boxes, select “no Gaussian Blur” to compute 
FRET images from native uFRET, donor and acceptor images; 
press on Constant button just below and fill the box with the 
calculated parameters A (in the Donor Model bookmark) and 
B (in the Acceptor Model bookmark); press Accept button.
 33. The Fc and normalized FRET images are calculated only if 
pixel values in each image are above a given threshold, set by 
default to average background values; the threshold correction 
factor is a multiplication factor applied to background values in 
order to modify this threshold; the pixels below the threshold 
are displayed in blue (or black in the new user’s LUT) in the 
computed Fc and normalized FRET images.
 34. The computed Fc and normalized FRET images are encoded 
on 32 bits but visualized on 256 color levels; the minimum 
value is displayed in black and the maximum value in white. 
Hence, an artificially amplified FRET signal may be observed 
in a cell where no FRET occurs (negative control). Users 
should therefore always:
 –  Check the amplitude of the FRET signal by performing a 
profile plot through the cell of interest and compare this 
amplitude to that of a negative control (such as with cells 
expressing the donor–acceptor couple free EGFP and 
mCherry-α-tubulin for example) and to that a positive 
control (such as with cells expressing the donor–acceptor 
couple EGFP-β-tubulin and mCherry-α-tubulin).
 –  Stack the image of interest with an image of a negative and 
a positive control for FRET in order to visualize both 
images with the same LUT scale.
 35. This procedure uses each cell or sub-region as its own internal 
standard; in addition, users can calculate %E in a neighboring 
cell that should be similar to the one of the internal standard.
 36. The significance of %E is discussed in ref. [38].
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